Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 4 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 3 days agovaccines as frequently in the last few years. According to the Centers for Disease Control and...
EU drug watchdog urges COVID-19 vaccine update
Medical Xpress· 5 days agoThe most widely circulating COVID variant worldwide is now JN.1, having overtaken the XBB family that is the target of the most recent vaccines, the...
Research strengthens case to treat COVID-19 with metformin, not ivermectin
Medical Xpress· 17 hours agoPatients with COVID-19 had lower viral loads if treated with metformin, according to new University...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 4 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
AstraZeneca admits rare side effect of COVID-19 vaccine
Homenewshere.com· 2 days agoPharmaceutical company AstraZeneca acknowledged in U.K. court documents that its COVID-19 vaccine...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 3 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 3 days agoCovid vaccine maker came out of the March quarter with a $3.07 loss per share, reversing from a...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 2 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...